Investigating the effect of thyme on arterial blood gases

Comparative study of the effect of thyme and N-acetylcysteine on arterial blood gas levels of intubated patients in intensive care units

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240609062057N2

Enrollment

Registered

2024-10-30

Start date

2024-11-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients hospitalized in intensive care units.

Interventions

Intervention 1: Intervention Group: Patients admitted to special care units receive the intervention treatment, which involves administering herbal thyme syrup for a minimum of 5 days. The dosage is 2

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients admitted to the intensive care unit Age 20 to 80 No underlying respiratory diseases Willingness to participate in the study Not allergic to thyme or walnuts GCS less than 8

Exclusion criteria

Exclusion criteria: GCS grate than 8 Allergy to thyme or nutmeg Unwillingness to participate in the study Age less than 20 years and more than 80 years

Design outcomes

Primary

Measure	Time frame
Arterial blood gases. Timepoint: Based on a study on the minimum effectiveness of thyme, the intervention group took 2 grams of herbal thyme syrup twice a day for 5 days. Method of measurement: The pulmonary secretions volume (in cc) and arterial blood gas parameters (O2 saturation, PH, HCO3, CO2.BE) were measured and recorded for both groups during this period.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoud Etedali

Khomein Faculty of Medical Sciences

masoud.etedali@khomeinums.ac.ir+98 86 4622 4142

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026